Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zhong Ji Longevity Science Group Limited ( (HK:0767) ) just unveiled an update.
Zhong Ji Longevity Science Group Limited has announced a further delay in sending a shareholder circular related to its planned acquisition of 25% of Asian Integrated Cell Laboratory Limited, a major and connected transaction that will be funded through the issuance of convertible notes under a specific mandate. The circular, which will include detailed information on the deal, independent advice, financial data on the target and notice of a special general meeting, is now expected to be dispatched by 30 April 2026, extending the timetable for shareholder review and approval of this strategic move.
The postponement reflects the company’s need for additional time to prepare and finalise certain required information, indicating that regulatory compliance and disclosure standards under Hong Kong’s Listing Rules are driving the revised schedule. While the delay may push back the execution of the acquisition and the related financing structure, it also suggests the board is prioritising thorough documentation to support independent assessment by shareholders and advisors, which could influence investor confidence and the pace of the group’s expansion in cell science services.
The most recent analyst rating on (HK:0767) stock is a Sell with a HK$0.47 price target. To see the full list of analyst forecasts on Zhong Ji Longevity Science Group Limited stock, see the HK:0767 Stock Forecast page.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited, incorporated in Bermuda and listed in Hong Kong, operates in the longevity and life-science related sector. The group is expanding its presence in advanced biomedical services through investments such as its planned acquisition of a stake in Asian Integrated Cell Laboratory Limited, a cell science-focused business in the region.
Average Trading Volume: 377,950
Technical Sentiment Signal: Hold
Current Market Cap: HK$312M
See more insights into 0767 stock on TipRanks’ Stock Analysis page.